Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-350-7 | CAS number: 56706-10-6
Endpoint summary
Administrative data
Description of key information
The key skin sensitisation study is a reliable adjuvant study conducted
according to OECD 406 on a closely related material. The study
identified a sensitization index of 5% (EU criteria for sensitization by
skin contact would require a positive response in at least 30% of the
test group).
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The key study for sensitisation was read across from the related substance polysulfides, bis[3-(triethoxysilyl)propyl] (CAS 211519-85-6), conducted according to an appropriate OECD test guideline, and in compliance with GLP, and found the test material not sensitising (WIL 2000).
The sensitization index was reported to be 5%. EU criteria for sensitization by skin contact would require a positive response in at least 30% of the test group. The test substance contained a mixture of the registered substance and the related S3 and S4 isomers, but the relative proportions of each are not known.
The registered substance contains S2 as the main constituent, with S3 present as an impurity.The substance in the study used for read across, Polysulfides (CAS 211519 -85 -6), contained up to 25% of the registered substance. The other constituents are the structurally similar analogue substances S3 and S4. Due to the structural similarity and similar physicochemical properties, the read-across substance is considered to be representative of the registered substance, as the Polysulfides gave a clear negative result and there is no reason to expect a positive result from a higher proportion of S2 constituent. See discussion in the reproductive toxicity section endpoint summary (Section 7.8, section 5.9 for the CSR) for a more detailed justification for the read-across approach.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available data, 4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane does not require classification for sensitisation according to Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
